NSAID-sensitive patients tolerate rofecoxib

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 57, Issue 12, 2002, Pages 1214-1215

  Valero, A ^a   Baltasar, M ^a   Enrique, E ^a   Pau, L ^a   Dordal, M T ^a   Cistero A ^a   Marti E ^a   Picado, C ^a  

^a Villarroel ^*

Author keywords

Angiedema; Asthma; Nonsteroidal anti inflammatory drug; NSAID; Rofecoxib; Urticaria

Indexed keywords

ACECLOFENAC; DICLOFENAC; IBUPROFEN; INDOMETACIN; MELOXICAM; NAPROXEN; NIFLUMIC ACID; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PIROXICAM; PYRAZOLONE DERIVATIVE; ROFECOXIB; SALSALATE; TENOXICAM;

ADULT; AGED; ANGIONEUROTIC EDEMA; ARTICLE; ASTHMA; CLINICAL TRIAL; DELAYED HYPERSENSITIVITY; DRUG MEGADOSE; DRUG SAFETY; DRUG SENSITIVITY; DRUG TOLERABILITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; PRIORITY JOURNAL; URTICARIA;

ADOLESCENT; ADULT; AGED; ANGIONEUROTIC EDEMA; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASTHMA; CONTROLLED CLINICAL TRIALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG HYPERSENSITIVITY; DRUG TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LACTONES; MALE; MIDDLE AGED; PEAK EXPIRATORY FLOW RATE; SINGLE-BLIND METHOD; SULFONES; URTICARIA;

EID: 0036950329     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2002.23893_6.x     Document Type: Article

References (7)

1. SETTIPANE RA, SCHRANK PJ, SIMON RA, MATHINSON DA, CHRISTIANSEN SC, STEVENSON DD. Prevalence of cross-sensitivity with acetominophen in aspirin-sensitive asthmatic subjects. J Allergy Clin Immunol 1995;96:480-485.
2. JOHANSSON SGO, HOURIHANE JO'B, BOUSQUET J, et al. A revised nomenclature for allergy. Am EAACI position statement from EAACI nomenclature task force. Allergy 2001;56:813-824.
3. SZCZEKLIK A, NIZANKOWSKA E, BOCHENEK G, NAGRABA K, MEJZA F, SWIERCZYNSKA M. Safety of specific COX-2 inhibitor in aspirin-induced asthma. Clin Exp Allergy 2001;31:219-225.
4. STEVENSON DD, SIMON RA. Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma. J Allergy Clin Immunol 2001;108:47-51.
5. ASERO R. Tolerability of rofecoxib. Allergy 2001;56:916-917.
6. SÁNCHEZ-BORGES M, CAPRILES-HULETT A, CABALLERO-FONSECA F. NSAID hypersensitivity in the COX-2 inhibitor era. ACI Int 2001;13:211-218.
7. NETTIS E, DI PAOLA R, FERRANNINI A, TURSI A. Tolerability of rofecoxib in patients with cutaneous adverse reaction to nonsteroidal anti-inflammatory drugs. Ann Allergy Asthma Immunol 2002;88:331-334.